ACQUIRED MULTICELLULAR-MEDIATED RESISTANCE TO ALKYLATING-AGENTS IN CANCER
ACQUIRED MULTICELLULAR-MEDIATED RESISTANCE TO ALKYLATING-AGENTS IN CANCER
复制标题
DOI:
10.1073/pnas.90.8.3294
复制
发表时间:
1993-04-15
影响因子:
11.1
通讯作者:
KERBEL, RS
中科院分区:
文献类型:
--
作者:
KOBAYASHI, H;MAN, S;KERBEL, RS
EMT-6 murine mammary tumor sublines highly resistant to cyclophosphamide, cis-diamminedichloro-platinum(II), or N,N',N''-triethylenethiophosphoramide were generated in vivo by sequential treatment of tumor-bearing mice with the respective drugs. Previous studies demonstrated the drug-resistant phenotypes of the sublines were not expressed in vitro when the cells were grown as monolayer cultures. We now show that expression of drug resistance- including patterns of cross-drug resistance observed in vivo- can be fully recapitulated in vitro when the cells are grown under in vivo-like, three-dimensional conditions-namely, as multicellular tumor spheroids. Moreover, the spheroids generated from all of the drug-resistant sublines manifested a much more compact structure. Immediate drug-sensitivity testing of single cells released by trypsin treatment from compact drug-resistant spheroids revealed that such cells lost much of their drug-resistant properties. The results suggest a possible mechanism of acquired drug resistance in tumors based on the response of a cell population (i.e., multicellular or tissue resistance) as opposed to classic (uni)cellular resistance mechanisms.